Genetic & Genomic MedicinemedRxivPreprint
Genetically informed drug target prioritisation and repurposing for major depressive disorder
Abigail ter Kuile, Chris Finan, Sandesh Chopade…·Jean‐Baptiste Pingault
This paper identifies and prioritizes drug targets for major depressive disorder using genetic methods, finding that 82% of approved depression/anxiety drugs have significant genetic targets.
DOI 10.1101/2025.07.15.25331558